Overall The mission of the Center for AIDS Research (CFAR) at Emory University is to decrease HIV incidence, improve well-being and, ultimately, find a vaccine and a cure for HIV by fostering and supporting trans- disciplinary research targeting the Southern epidemic as a microcosm of the global HIV/AIDS pandemic. The Emory CFAR has been extremely successful in strategically expanding a University-wide, multidisciplinary community of scientists whose NIH-funded research has led to globally recognized interventions that prevent new HIV transmissions and enhance the wellbeing of people living with and at risk for HIV. Over its 18-year history, the Emory CFAR has become the cornerstone of Emory's HIV research community and has brought the University to world prominence as a center of excellence in HIV/AIDS research. During the current project period the Emory CFAR Executive Leadership maintained a focus on immunology and pathogenesis while also greatly expanding the CFAR's capacity to provide innovative and comprehensive clinical, prevention science, and biostatistical support to HIV researchers. We have also strengthened our ties with the community through substantive partnerships with community-based, state, and national public health agencies that are focusing attention on the Southern HIV epidemic. The CFAR's success in providing Value Added to Emory University is widely acknowledged by the University leadership that has committed $3M in institutional support for the CFAR from the offices of the Emory University President, Provost, and all five units of the Woodruff Health Science Center (Emory School of Medicine, Rollins School of Public Health, Nell Hodgson Woodruff School of Nursing, Winship Cancer Institute, and Yerkes National Primate Research Center). In addition, the Georgia Research Alliance, an external partner that promotes the growth of research in Georgia, continues their commitment to support the CFAR through the purchase of research equipment and funds for laboratory infrastructure needs. As a means of fulfilling the mission of the CFAR we propose specifically to 1) Develop, support, and expand high priority HIV/AIDS research that will prevent new infections, improve the well-being of people with or at risk for HIV, and move toward the discovery of a vaccine and a cure; 2) Translate and disseminate HIV/AIDS research findings; 3) Identify, train, mentor, and support the next generation of HIV/AIDS researchers and scientific leaders. In this way we are confident that the Emory CFAR will continue to build on its successes to develop a comprehensive research program that makes significant contributions to ending the HIV epidemic. This application is for a Center for AIDS Research award.

Public Health Relevance

In the 21st century the mitigation of suffering from HIV/AIDS remains a global challenge. The mission of the Center for AIDS Research (CFAR) at Emory University is to decrease HIV incidence, improve well-being and, ultimately, find a vaccine and a cure for HIV by fostering and supporting trans-disciplinary research targeting the Southern US epidemic as a microcosm of the global HIV/AIDS pandemic. This project will foster career development of young HIV investigators and provide innovative and comprehensive HIV research support services for new and established researchers through five science cores ? Clinical Research, Prevention Science, Biostatistics & Bioinformatics, Immunology, and Virology & Molecular Biomarkers ? and two scientific working groups: HIV & Aging and HIV Cure.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Refsland, Eric William
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Emory University
Public Health & Prev Medicine
Schools of Public Health
United States
Zip Code
Adekambi, Toidi; Ibegbu, Chris C; Cagle, Stephanie et al. (2018) High Frequencies of Caspase-3 Expressing Mycobacterium tuberculosis-Specific CD4+ T Cells Are Associated With Active Tuberculosis. Front Immunol 9:1481
Carnathan, Diane; Lawson, Benton; Yu, Joana et al. (2018) Reduced Chronic Lymphocyte Activation following Interferon Alpha Blockade during the Acute Phase of Simian Immunodeficiency Virus Infection in Rhesus Macaques. J Virol 92:
Eckard, Allison Ross; O'Riordan, Mary Ann; Rosebush, Julia C et al. (2018) Vitamin D supplementation decreases immune activation and exhaustion in HIV-1-infected youth. Antivir Ther 23:315-324
Ende, Zachary; Deymier, Martin J; Claiborne, Daniel T et al. (2018) HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs. J Virol :
Patel, Viraj V; Dange, Alpana; Rawat, Shruta et al. (2018) Barriers to HIV Testing Among Men Who Have Sex With Men in India Reached Online: Implications for Interventions. J Acquir Immune Defic Syndr 78:e30-e34
Haddad, Lisa B; Wall, Kristin M; Kilembe, William et al. (2018) Bacterial vaginosis modifies the association between hormonal contraception and HIV acquisition. AIDS 32:595-604
Zuniga, Julie A; Easley, Kirk A; Shenvi, Neeta et al. (2018) The impact of diabetes on CD4 recovery in persons with HIV in an urban clinic in the United States. Int J STD AIDS 29:63-71
Joseph Davey, Dvora Leah; Wall, Kristin M; Kilembe, William et al. (2018) Difficult decisions: Evaluating individual and couple-level fertility intentions and HIV acquisition among HIV serodiscordant couples in Zambia. PLoS One 13:e0189869
Georgieva, Maria; Sia, Jonathan Kevin; Bizzell, Erica et al. (2018) Mycobacterium tuberculosis GroEL2 Modulates Dendritic Cell Responses. Infect Immun 86:
Sam, Soya S; Caliendo, Angela M; Ingersoll, Jessica et al. (2018) Performance evaluation of the Aptima HSV-1 and 2 assay for the detection of HSV in cutaneous and mucocutaneous lesion specimens. J Clin Virol 99-100:1-4

Showing the most recent 10 out of 1005 publications